While OTX2 genomic copy number gain is known to drive aberrant OTX2 expression in a subset (∼21%) of medulloblastomas [5], [19], [32], [33], alternative mechanisms of OTX2 overexpression have not been previously described. Here, OTX2 is linked to medulloblastoma.